[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552679":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":23,"locations":23,"responsibleParty":26,"collaborators":23,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":35,"acronym":23,"eligibilityCriteria":36,"healthyVolunteers":32,"sex":37,"minAge":38,"maxAge":23,"enrollmentInfo":39,"targetDuration":23,"studyType":42,"phases":43,"briefSummary":45,"conditions":46,"keywords":23,"overallStatus":48,"whyStopped":23,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":54,"leadSponsor":56,"locationsCount":23},{"fullName":5,"class":6},"Chulalongkorn University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Artificial saliva containing cumin and ginger extract","EXPERIMENTAL","The sample will be sprayed 2 puff\u002Ftime, 3 times\u002Fday, for 14 days.",[13],"Drug: Artificial saliva containing cumin and ginger extract",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo","PLACEBO_COMPARATOR",[18],"Drug: Placebo",[20,24],{"type":21,"name":9,"description":11,"armGroupLabels":22,"otherNames":23},"DRUG",[9],null,{"type":21,"name":15,"description":11,"armGroupLabels":25,"otherNames":23},[15],{"type":27,"investigatorFullName":28,"investigatorTitle":29,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Pornanong Aramwit, Pharm.D., Ph.D","Professor","100552679","artificial-saliva-containing-cumin-and-ginger-extract-in-hemodialysis-patients-with-xerostomia-100552679",false,"NCT06476223","Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia","Efficacy and Safety of Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis","Inclusion Criteria:\n\n* Age more than 18 years\n* Hemodialysis patients with xerostomia (saliva flow rate less than 0.2 g\u002Fmin)\n* Hemodialysed history more than 3 months\n* Be willing to participate in the study\n\nExclusion Criteria:\n\n* Patients with sialolith or Sjogren's syndrome\n* Uncontrolled other diseases\n* Using artificial saliva for more than 2 weeks\n* Taking pilocarpine and cevimeline\n* Allergic to ginger, cumin, xylitol, and glycerin\n* Have mucositis\n* Pregnancy or lactation","ALL","18 Years",{"count":40,"type":41},26,"ESTIMATED","INTERVENTIONAL",[44],"NA","Hemodialysis patients with xerostomia are divided into 2 groups which are group A (start with artificial saliva containing cumin and ginger extract for 2 weeks, free periods 2 weeks, then placebo for 2 weeks) and group B (start with placebo for 2 weeks, free periods 2 weeks, then artificial saliva containing cumin and ginger extract for 2 weeks). Amount of saliva (g\u002Fmin), xerostomia's questionnaire, Increase of saliva score, World Health Organization Oral Mucositis Grading Scale, acid and base of saliva, quality of life's questionnaire will measure before, after using the sample for 7 and 14 days.",[47],"Xerostomia","NOT_YET_RECRUITING","2024-06-28",{"date":51,"type":52},"2024-07-01","ACTUAL",{"date":51,"type":41},{"date":55,"type":41},"2025-01-31",{"name":5,"class":6}]